Nanda Palanichamy

Nanda Palanichamy

Nanda Palanichamy, Consultant Psychiatrist

What has been your greatest clinical challenge in the past year?

I think the most challenging case that I faced recently was a diagnostic conundrum where there were a lot of psychotic symptoms in a patient who had a long history of schizophrenia. However, the emerging evidence was that it was more bipolar I disorder with psychotic symptoms; so I find it particularly challenging to determine whether people are presenting with psychotic symptoms and a diagnosis of schizoaffective disorder or purely an affective disorder with psychotic symptoms.

Do you think a patient’s family or loved ones should be included in the management and treatment of their disorder? If so, what is the best way to include family or loved ones?

I think it’s very important to include family because especially when people are in mania or having extensive psychotic symptoms it’s difficult for them to have insight all the time and that poses a particular challenge in persuading them to partake in treatment for bipolar I disorder. I think it is very important to involve the family very early on in their treatment, as soon as the diagnosis has been made for the first time. This is because I think it prevents further relapses and suicidal risk, which is high in bipolar disorder.

 

Our correspondent’s highlights from the symposium are meant as a fair representation of the scientific content presented. The views and opinions expressed on this page do not necessarily reflect those of Lundbeck.

Country selection
We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil
You are leaving Progress in Mind
Hello
Please confirm your email
We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.
The information on this site is exclusively intented for health care professionals.
All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.
Congress
Register for access to Progress in Mind in your country